Phosphorylated ERK is a potential predictor of sensitivity to sorafenib when treating hepatocellular carcinoma: evidence from an in vitrostudy
Zhe Zhang(Sun Yat-sen University), Yanhong Wang(Xuzhou Medical College)
Cited by 147
Related Papers
Tadalafil Augments Tumor Specific Immunity in Patients with Head and Neck Squamous Cell Carcinoma
|Clinical Cancer Research|2015|184
Schedule-dependent antitumor effects of 5-fluorouracil combined with sorafenib in hepatocellular carcinoma
|BMC Cancer|2013|21